S. Escaich

发表

From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.

N. Desroy, F. Moreau, V. Gerusz, 2012, Journal of medicinal chemistry.

Stereoselective glycal fluorophosphorylation: synthesis of ADP-2-fluoroheptose, an inhibitor of the LPS biosynthesis.

S. Grizot, A. Ducruix, M. Durka, 2008, Chemistry.

Comparison of HIV detection by virus isolation in lymphocyte cultures and molecular amplification of HIV DNA and RNA by PCR in offspring of seropositive mothers.

Y. Bertrand, C. Trépo, D. Raudrant, 1991, Journal of acquired immune deficiency syndromes.

A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.

B. Roques, C. Dong, A. Bousseau, 1999, Proceedings of the National Academy of Sciences of the United States of America.

REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis

Y. Henrotin, C. Vêtu, R. Montjean, 2020, PloS one.

Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro.

H. Matsuzaki, S. Forestell, L. Su, 1997, Blood.

HIV‐1ヌクレオカプシド蛋白質模倣体は逆転写を阻害し,抗ウイルス活性を示す

A. Bousseau, S. Druillennec, S. Escaich, 1999 .

Identiﬁcation of Candidates for a Subunit Vaccine against Extraintestinal Pathogenic Escherichia coli (cid:1) †

X. Nassif, S. Escaich, L. Durant, 2007 .

RegR, a Global LacI/GalR Family Regulator, Modulates Virulence and Competence in Streptococcus pneumoniae

A. Ogunniyi, J. Desnottes, J. Paton, 2003, Infection and Immunity.

Antivirulence as a new antibacterial approach for chemotherapy.

S. Escaich, 2008, Current opinion in chemical biology.

Towards Gram-positive antivirulence drugs: New inhibitors of Streptococcus agalactiae Stk1

F. Moreau, V. Gerusz, A. Denis, 2010 .

Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.

I. Plavec, K. Moss, E. Böhnlein, 1996, Gene therapy.

Detection of intracellular HIV-1 Rev protein by flow cytometry.

I. Plavec, E. Böhnlein, S. Escaich, 1995, Journal of immunological methods.

Detection of human immunodeficiency virus-DNA and RNA in the skin of HIV-infected patients using the polymerase chain reaction.

Jean Kanitakis, J. Thivolet, S. Escaich, 1991, The Journal of investigative dermatology.

Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.

N. Desroy, F. Moreau, V. Gerusz, 2008, Bioorganic & medicinal chemistry letters.

The MUT056399 Inhibitor of FabI Is a New Antistaphylococcal Compound

I. Morrissey, F. Moreau, S. Escaich, 2011, Antimicrobial Agents and Chemotherapy.

Comparative Analyses of Intracellularly Expressed Antisense RNAs as Inhibitors of Human Immunodeficiency Virus Type 1 Replication

H. Kaneshima, E. Böhnlein, G. Veres, 1998, Journal of Virology.

Replication Human Immunodeficiency Virus Type 1 Expressed Antisense RNAs as Inhibitors of Comparative Analyses of Intracellularly

G. Veres, Creton, H. Kaneshima, 1997 .

Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes

G. Veres, H. Kaneshima, E. Böhnlein, 1996, Journal of virology.

Inhibition de la replication du vih-1 au moyen de l'expression d'arn antisens

G. Veres, E. Boehnlein, H. Ilves, 1997 .

Intracellular expression of cellular eIF-5A mutants inhibits HIV-1 replication in human T cells: a feasibility study.

J. Hauber, E. Böhnlein, S. Escaich, 1996, Human gene therapy.

Identification of Candidates for a Subunit Vaccine against Extraintestinal Pathogenic Escherichia coli

X. Nassif, S. Escaich, L. Durant, 2006, Infection and Immunity.

RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells.

I. Plavec, J. Mosca, E. Böhnlein, 1995, Human gene therapy.

High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS

H. Matsuzaki, I. Plavec, M. Pineda, 1997, Gene Therapy.

Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines

C. Craik, I. Plavec, J. Rosé, 1996, Journal of virology.

Relevance of the quantitative detection of HIV proviral sequences in PBMC of infected individuals.

P. Rougier, J. Lamelin, C. Trépo, 1992, AIDS research and human retroviruses.

Prognostic value of kinetic parameters of HIV isolation from peripheral blood mononuclear cells.

L. Cotte, C. Trépo, S. Escaich, 1992, Research in virology.

Plasma viraemia as a marker of viral replication in HIV-infected individuals.

P. Rougier, J. Lamelin, C. Trépo, 1991, AIDS.

Novel agents to inhibit microbial virulence and pathogenicity

Sonia Escaich, S. Escaich, 2010, Expert opinion on therapeutic patents.

Functional Epitope Analysis of the Human CD 11 a/CD 18 Molecule (LFA‐1, Lymphocyte Function‐Associated Antigen 1) Involved in HIV‐1‐Induced Syncytium Formation

D. Rigal, J. Lamelin, C. Trépo, 1991, Scandinavian journal of immunology.

Towards Gram-negative antivirulence drugs: new inhibitors of HldE kinase.

N. Desroy, F. Moreau, V. Gerusz, 2009, Bioorganic & medicinal chemistry.

Novel HldE-K inhibitors leading to attenuated Gram negative bacterial virulence.

M. Junop, N. Desroy, F. Moreau, 2013, Journal of medicinal chemistry.

Structure of the Escherichia coli heptosyltransferase WaaC: binary complexes with ADP and ADP-2-deoxy-2-fluoro heptose.

S. Grizot, A. Ducruix, F. Moreau, 2006, Journal of molecular biology.

Towards Gram-positive antivirulence drugs: new inhibitors of Streptococcus agalactiae Stk1.

F. Moreau, V. Gerusz, A. Denis, 2010, Bioorganic & medicinal chemistry letters.

Antivirulence as a new antibacterial approach for chemotherapy.

S. Escaich, 2008, Current opinion in chemical biology.